Curtis Nathan, Vohra Hunaid A, Ohri Sunil K
Wessex Cardiothoracic Department, Southampton General Hospital, Southampton, UK.
Perfusion. 2010 May;25(3):115-24. doi: 10.1177/0267659110371705.
Improved knowledge of the pathophysiological processes experienced in response to cardiopulmonary bypass has led to new developments in extracorporeal technology and understanding. The use of mini extracorporeal circuits (MECC) is rapidly expanding in clinical practice. The mini extracorporeal circuit differs by a greatly reduced tubing length and the number of components when compared with current circuit designs. The MECC is believed to offer potential benefits to the surgical patient by reducing the systemic inflammatory response that remains strongly implicated in post-operative organ dysfunction. We present a review of the available literature and find the MECC to show an acceptable safety profile with a reduction in post-operative complications and transfusion requirements and no evidence of any negative impairment to the surgeon, anaesthetist or perfusionist. The observed post-bypass inflammatory response is seen to be lower after MECC bypass and this is of clear clinical benefit.
对体外循环所经历的病理生理过程的深入了解,推动了体外技术及认知方面的新进展。微型体外循环回路(MECC)在临床实践中的应用正在迅速扩展。与当前的回路设计相比,微型体外循环回路的管路长度和组件数量大幅减少。MECC被认为通过减少与术后器官功能障碍密切相关的全身炎症反应,为手术患者带来潜在益处。我们对现有文献进行了综述,发现MECC显示出可接受的安全性,术后并发症和输血需求减少,且没有证据表明对外科医生、麻醉师或灌注师有任何负面损害。MECC体外循环后观察到的旁路后炎症反应较低,这具有明显的临床益处。